ANGION BIOMEDICA CORP
COM · CUSIP 03476J107
0
institutional holders
-29 vs Q1 2023
—reported value*
0 new
0 added
0 reduced
29 sold out
net sold ≈ $2.6m (-4.5m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 38 |
| Q4 2022 | 31 |
| Q1 2023 | 29 |
| Q2 2023 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 6 | 18 |
| Q1 2023 | 7 | 9 |
| Q2 2023 | 0 | 29 |
Biggest buyers
| None |
Biggest sellers
| BVF INC/IL | Sold out | -1.1m |
| Nantahala Capital Management, LLC | Sold out | -982.7k |
| CM Management, LLC | Sold out | -800.0k |
| VANGUARD GROUP INC | Sold out | -644.0k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | Sold out | -175.0k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -167.4k |
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -93.0k |
| MILLENNIUM MANAGEMENT LLC | Sold out | -69.4k |
| RAYMOND JAMES & ASSOCIATES | Sold out | -60.0k |
| BlackRock Inc. | Sold out | -57.1k |
Holders, Q2 2023
| Manager | Shares | Change |
|---|